Closed 9.4 million financing May 2017 (sufficient for 1st half 2018)
QUOTE “Significant progress in the last few months” 2 products in trials with great results They own their virus manufacturing plant in the EU. (Very difficult for a company to source third party viruses for testing)
I recommend going to the APHB website and reading the updated “presentations”. It explains a lot.